{{Rsnum
|rsid=2270861
|Gene=UTP20
|Chromosome=12
|position=101342603
|Orientation=plus
|GMAF=0.2686
|Gene_s=UTP20
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 59.8 | 35.7 | 4.5
| HCB | 35.6 | 50.4 | 14.1
| JPT | 41.1 | 42.0 | 17.0
| YRI | 76.2 | 23.1 | 0.7
| ASW | 76.4 | 16.4 | 7.3
| CHB | 35.6 | 50.4 | 14.1
| CHD | 36.1 | 48.1 | 15.7
| GIH | 67.0 | 32.0 | 1.0
| LWK | 63.9 | 33.3 | 2.8
| MEX | 50.0 | 43.1 | 6.9
| MKK | 60.0 | 36.8 | 3.2
| TSI | 50.5 | 41.6 | 7.9
| HapMapRevision=28
}}

{{PMID Auto
|PMID=17903303
|Title=Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}